Preprocedural statin use is associated with a reduced hazard of postprocedural myonecrosis in patients undergoing rotational atherectomy—a propensity-adjusted analysis - 17/08/11
Doi : 10.1016/j.ahj.2006.02.026
Hitinder S. Gurm, MD a, ⁎ 
, Yuri Breitbart, DSc b, Deepak Vivekanathan, MD a, Michael H. Yen, MD a, Robert Fathi, MBBS, PhD a, Khaled M. Ziada, MD a, Patrick L. Whitlow, MD a, Stephen G. Ellis, MD a
, Yuri Breitbart, DSc b, Deepak Vivekanathan, MD a, Michael H. Yen, MD a, Robert Fathi, MBBS, PhD a, Khaled M. Ziada, MD a, Patrick L. Whitlow, MD a, Stephen G. Ellis, MD a a Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH
b Department of Computer Science, Kent State University, Kent, OH
⁎Reprint requests: Hitinder S Gurm, MBBS, Division of Cardiovascular Medicine, University of Michigan, TC B1-226, 1500 E Medical Ctr Drive, Ann Arbor, MI 48109-0311.
Résumé |
Incidence of myonecrosis in patients undergoing rotational atherectomy was evaluated by preprocedural statin use. The incidence of any myonecrosis (24.1% vs 52.3%, P < .001) or significant myonecrosis (7.5% vs 21.8%, P < .001) was significantly lower among patients pretreated with statins. This difference remained significant after multivariable and propensity adjustment.
Le texte complet de cet article est disponible en PDF.Plan
| This study had no external funding and none of the authors have a conflict of interest. All work presented in this analysis was preformed at the Cleveland Clinic Foundation. |
© 2006
Mosby, Inc. Tous droits réservés.
Vol 151 - N° 5
P. 1031.e1-1031.e6 - mai 2006 Retour au numéro
Article précédent
- Influence of sex on in-hospital outcomes and long-term survival after contemporary percutaneous coronary intervention
- Jeffrey S. Berger, Timothy A. Sanborn, Warren Sherman, David L. Brown
- Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: A subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)–2 trial
- Matthews Chacko, A. Michael Lincoff, Katherine E. Wolski, David J. Cohen, John A. Bittl, Alexandra J. Lansky, Yoshihiro Tsuchiya, Amadeo Betriu, Michael H. Yen, Derek P. Chew, Leslie Cho, Eric J. Topol
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?